Both in Pharmaceuticals
Seres Therapeutics vs Edesa Biotech
Over the past year MCRB returned −87.7% and EDSA returned +5.2%; their daily moves had a correlation of 0.03.
MCRB −87.7% EDSA +5.2%Growth of $1, one year, split-adjusted
| Metric | MCRB | EDSA |
|---|---|---|
| Price | $2.30 | $2.85 |
| Market cap | $23.1M | $27.5M |
| Today | −0.43% | +1.06% |
| 1 month | −42.8% | −30.0% |
| 6 months | −72.7% | −59.5% |
| Year to date | −84.5% | +100.7% |
| 1 year | −87.6% | +17.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 622.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 12.3× | — |
| Net cash | $15.6M | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.8% | 89.2% |
| Short % of float | 4.5% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).